Associate Professor Irina Stepanov talks about heated tobacco products, how the new iQOS device works, and what the potential harms and benefits of iQOS are to public health.
The results of a study led by PhD student Xuanzi Qin suggest the potential benefits of screening may be more readily understood and appreciated by women.
The study results from student Jeremy Van’t Hof and Professor Russell Luepker suggest that people may feel a greater sense of CVD prevention accountability and social support in community settings.
Assistant Professor Eric Lock has received a $1-million grant from the NIH to develop new methods to analyze multi-source and multi-way data all together at the same time.
A study by researcher Stuart Grande shows mHealth apps, such as Genia, help children with Juvenile Idiopathic Arthritis share their needs and experiences with their families and care teams.
Associate Professor Pamela Lutsey found that DOAC drugs appear to be just as safe to use as heparin and warfarin for treating venous thromboembolism in cancer patients.
The method developed by Assistant Professor Silvia Balbo may help researchers uncover the genetic chemistry leading to cancer development, which has broad applications ranging from understanding how toxins are affecting DNA in the body to developing tools to improve outcomes of chemotherapy.
A study by Associate Professor Sonya Brady shows that the “Communities That Care” model helps local stakeholders work together to analyze and stop some of the major health issues threatening their own neighborhoods.
Professor Michael Osterholm is leading research to improve the healthcare system’s ability to maintain a steady and adequate amount of critical medicines and supplies worldwide.
Regents Professor Michael Osterholm is leading the effort aimed at accelerating progress toward creating universal influenza vaccines.
Assistant Professor Dori Cross found that the use of health information exchange portals in skilled nursing facilities is languishing due to multiple barriers to their timely and consistent use.
Recent research by Assistant Professor Nicole Basta reveals that only 20 percent of parents are aware that a vaccine to protect their children against meningococcal B disease exists.